These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 10816483
1. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium. McSorley SJ, Jenkins MK. Infect Immun; 2000 Jun; 68(6):3344-8. PubMed ID: 10816483 [Abstract] [Full Text] [Related]
3. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. Mittrücker HW, Raupach B, Köhler A, Kaufmann SH. J Immunol; 2000 Feb 15; 164(4):1648-52. PubMed ID: 10657605 [Abstract] [Full Text] [Related]
4. Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi. Xiong K, Zhu C, Chen Z, Zheng C, Tan Y, Rao X, Cong Y. Front Cell Infect Microbiol; 2017 Feb 15; 7():135. PubMed ID: 28484685 [Abstract] [Full Text] [Related]
6. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen. McKelvie ND, Khan SA, Karavolos MH, Bulmer DM, Lee JJ, DeMarco R, Maskell DJ, Zavala F, Hormaeche CE, Khan CM. FEMS Immunol Med Microbiol; 2008 Mar 15; 52(2):237-46. PubMed ID: 18177343 [Abstract] [Full Text] [Related]
7. Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Mastroeni P, Simmons C, Fowler R, Hormaeche CE, Dougan G. Infect Immun; 2000 Jan 15; 68(1):46-53. PubMed ID: 10603367 [Abstract] [Full Text] [Related]
8. Innate immunity mediated by MyD88 signal is not essential for induction of lipopolysaccharide-specific B cell responses but is indispensable for protection against Salmonella enterica serovar Typhimurium infection. Ko HJ, Yang JY, Shim DH, Yang H, Park SM, Curtiss R, Kweon MN. J Immunol; 2009 Feb 15; 182(4):2305-12. PubMed ID: 19201885 [Abstract] [Full Text] [Related]
9. Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes. Matsui H, Fukiya S, Kodama-Akaboshi C, Eguchi M, Yamamoto T. J Med Microbiol; 2015 Mar 15; 64(Pt 3):295-302. PubMed ID: 25589672 [Abstract] [Full Text] [Related]
11. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate. Xiong K, Chen Z, Zhu C, Li J, Hu X, Rao X, Cong Y. Int J Med Microbiol; 2015 Sep 15; 305(6):563-71. PubMed ID: 26239100 [Abstract] [Full Text] [Related]
12. Gamma irradiation or CD4+-T-cell depletion causes reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice. van Diepen A, van de Gevel JS, Koudijs MM, Ossendorp F, Beekhuizen H, Janssen R, van Dissel JT. Infect Immun; 2005 May 15; 73(5):2857-62. PubMed ID: 15845491 [Abstract] [Full Text] [Related]
13. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice. Lee HY, Cho SA, Lee IS, Park JH, Seok SH, Baek MW, Kim DJ, Lee SH, Hur SJ, Ban SJ, Lee YK, Han YK, Cho YK, Park JH. FEMS Immunol Med Microbiol; 2007 Nov 15; 51(2):310-8. PubMed ID: 17725620 [Abstract] [Full Text] [Related]
14. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection. Paliwal PK, Bansal A, Sagi SS, Sairam M. Vaccine; 2011 Sep 02; 29(38):6532-9. PubMed ID: 21767594 [Abstract] [Full Text] [Related]
15. Vaccination Method Affects Immune Response and Bacterial Growth but Not Protection in the Salmonella Typhimurium Animal Model of Typhoid. Kinnear CL, Strugnell RA. PLoS One; 2015 Sep 02; 10(10):e0141356. PubMed ID: 26509599 [Abstract] [Full Text] [Related]
16. Characterization of an outer membrane protein of Salmonella enterica serovar typhimurium that confers protection against typhoid. Hamid N, Jain SK. Clin Vaccine Immunol; 2008 Sep 02; 15(9):1461-71. PubMed ID: 18650399 [Abstract] [Full Text] [Related]
17. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D. Clin Vaccine Immunol; 2007 Oct 02; 14(10):1285-95. PubMed ID: 17687110 [Abstract] [Full Text] [Related]
18. Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells. Tobar JA, Carreño LJ, Bueno SM, González PA, Mora JE, Quezada SA, Kalergis AM. Infect Immun; 2006 Nov 02; 74(11):6438-48. PubMed ID: 17057096 [Abstract] [Full Text] [Related]
19. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever. Das S, Chowdhury R, Pal A, Okamoto K, Das S. Immunobiology; 2019 May 02; 224(3):371-382. PubMed ID: 30952553 [Abstract] [Full Text] [Related]
20. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated Salmonella enterica Serovar Typhimurium Vaccine Strains. Łaniewski P, Baek CH, Roland KL, Curtiss R. mBio; 2017 Aug 22; 8(4):. PubMed ID: 28830946 [Abstract] [Full Text] [Related] Page: [Next] [New Search]